Export

Eurofins Biopharma Product Testing Sweden AB

Financial information

The information source is the annual report of the company with business id 556225-2196

* Closing information (×1000) SEK

Fiscal year 202312 202212
Number of months: 12 12
Turnover: 67,508 Revenue Up 61,765 Revenue Up
Financial expenses: 2,592 Revenue Up 1,675 Revenue Up
Earnings before taxes: -20,374 Revenue Up -21,022 Revenue Up
Total assets: 36,643 Revenue Down 46,159 Revenue Down
Current assets: 21,057 Revenue Down 26,015 Revenue Down
Current liabilities: 21,816 Revenue Up 13,888 Revenue Down
Equity capital: -18,668 Revenue Down 1,668 Revenue Down
Share capital: 100 100
Number of employees: 46 Revenue Down 50 Revenue Down

Financial ratios

Solvency: -50.9% Revenue Down 3.6% Revenue Down
Turnover per employee: 1,468 Revenue Up 1,235 Revenue Up
Profitability: -30.2% Revenue Up -34.0% Revenue Up
Return on equity (ROE): 109.1% Revenue Up -1.260.3% Revenue Down
Current ratio: 96.5% Revenue Down 187.3% Revenue Down
Return on assets (ROA): -48.5% Revenue Down -41.9% Revenue Down

Companies with similar products and services, and with detailed information

Fiscal year 202312
Number of months: 12
Turnover: 67,508
Financial expenses: 2,592
Earnings before taxes: -20,374
Total assets: 36,643
Current assets: 21,057
Current liabilities: 21,816
Equity capital: -18,668
Share capital: 100
Number of employees: 46

Financial ratios

Solvency: -50.9%
Turnover per employee: 1,468
Profitability: -30.2%
Return on equity (ROE): 109.1%
Current ratio: 96.5%
Return on assets (ROA): -48.5%